Cytek Biosciences Ownership
Who are the major shareholders and have insiders been buying or selling?
Recent Insider Transactions
Date | Value | Name | Entity | Role | Shares | Max Price |
---|---|---|---|---|---|---|
19 Sep 23 | SellUS$38,339,607 | RA Capital Management, L.P. | Company | 5,488,317 | US$7.15 |
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Ownership Breakdown
Owner Type | Number of Shares | Ownership Percentage |
---|---|---|
State or Government | 27,374 | 0.0209% |
Individual Insiders | 11,574,232 | 8.82% |
VC/PE Firms | 13,466,434 | 10.3% |
General Public | 38,819,822 | 29.6% |
Institutions | 67,385,067 | 51.3% |
Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.
Top Shareholders
Ownership | Name | Shares | Current Value | Change % | Portfolio % | |
---|---|---|---|---|---|---|
17,425,971 | US$94.6m | -1.99% | no data | |||
12,022,014 | US$65.3m | 0.05% | 0.93% | |||
12,012,805 | US$65.2m | 1.03% | no data | |||
6,809,404 | US$37.0m | 0% | 0.5% | |||
6,657,030 | US$36.1m | 0% | 0.31% | |||
5,995,937 | US$32.6m | -0.24% | no data | |||
5,326,154 | US$28.9m | 0.42% | no data | |||
4,115,859 | US$22.3m | 2.95% | no data | |||
2,949,008 | US$16.0m | 0.03% | 0.02% | |||
2,508,016 | US$13.6m | 2.1% | no data | |||
1,375,507 | US$7.5m | 29.2% | no data | |||
1,354,970 | US$7.4m | 4.93% | no data | |||
1,130,622 | US$6.1m | -5.04% | no data | |||
900,993 | US$4.9m | 0% | no data | |||
804,261 | US$4.4m | 3.82% | no data | |||
631,958 | US$3.4m | 20.4% | 0.02% | |||
573,600 | US$3.1m | 0% | no data | |||
550,512 | US$3.0m | 4.43% | no data | |||
517,790 | US$2.8m | 0% | 1.34% | |||
507,592 | US$2.8m | 2,040% | 0.01% | |||
487,550 | US$2.6m | 0% | 0.57% | |||
480,144 | US$2.6m | -7.43% | no data | |||
370,686 | US$2.0m | 4.92% | no data | |||
355,436 | US$1.9m | 5.37% | no data | |||
302,499 | US$1.6m | 0% | no data |